Curaleaf · 5 hours ago
Pharmacist
Curaleaf is a leading global cannabis provider committed to quality and innovation. As a Pharmacist, you will ensure compliant distribution of cannabis products, educate patients, and support retail operations in a collaborative environment.
Alternative MedicineCannabisHealth CareMedical
Responsibilities
Provide patients with accurate product recommendations, dosing, consumption methods, and product details
Assist patients with questions, concerns, and complaints, adjusting recommendations and/or dosing based on patient feedback
Train team members on product knowledge, ensuring they provide proper recommendations to patients
Build and maintain relationships with physicians, patients, politicians, and professionals in the community
Deepen your understanding of cannabis products, dosing, drug interactions, side effects, and the efficacy of different strains and delivery methods
Ensure compliance with company policies, procedures, and all federal and state laws. Oversee inventory audits and dispensing operations
Assist with inventory forecasting, product intake, and maintaining systems for regulatory reporting and sales analysis
Qualification
Required
An active Pharmacy License in the state you're applying for
Strong knowledge of the retail and pharmacy landscape
A passion for patient care and the medical cannabis industry
Effective communication skills at all levels inside and outside the organization
Outstanding customer service skills, with the ability to address concerns professionally
Flexibility with scheduling, able to work nights, weekends, and holidays as needed
Benefits
Career Growth Opportunities
Competitive Pay and Benefits
Generous PTO and Parental Leave
401(K) Retirement Plan
Life/ Disability Insurance
Community Involvement
Referral Bonuses and Product Discounts
Company
Curaleaf
Curaleaf operates as a vertically integrated medical and wellness cannabis producer.
Funding
Current Stage
Public CompanyTotal Funding
$1.45BKey Investors
Needham BankCapStone Holdings
2025-10-14Post Ipo Debt· $100M
2025-01-31Post Ipo Debt· $67M
2024-11-06Post Ipo Debt· $40M
Recent News
2025-12-29
2025-12-26
Company data provided by crunchbase